APA (7th ed.) Citation

Otaru, S., Paulus, A., Imlimthan, S., Kuurne, I., Virtanen, H., Liljenbäck, H., . . . Airaksinen, A. J. (2022). Development of [ 18 F]AmBF 3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [ 18 F]AmBF 3 -PEG 7 -Tyr 3 -Octreotide in an AR42J Pancreatic Carcinoma Model. Bioconjugate chemistry, 33(7), 1393-1404. https://doi.org/10.1021/acs.bioconjchem.2c00231

Chicago Style (17th ed.) Citation

Otaru, Sofia, et al. "Development of [ 18 F]AmBF 3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [ 18 F]AmBF 3 -PEG 7 -Tyr 3 -Octreotide in an AR42J Pancreatic Carcinoma Model." Bioconjugate Chemistry 33, no. 7 (2022): 1393-1404. https://doi.org/10.1021/acs.bioconjchem.2c00231.

MLA (9th ed.) Citation

Otaru, Sofia, et al. "Development of [ 18 F]AmBF 3 Tetrazine for Radiolabeling of Peptides: Preclinical Evaluation and PET Imaging of [ 18 F]AmBF 3 -PEG 7 -Tyr 3 -Octreotide in an AR42J Pancreatic Carcinoma Model." Bioconjugate Chemistry, vol. 33, no. 7, 2022, pp. 1393-1404, https://doi.org/10.1021/acs.bioconjchem.2c00231.